NEOG — NEOGEN CORP
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 711377 ·
Last close
$13.72
Market Cap
$2.99B
52W High
$14.26
52W Low
$5.37
ADV30
2,802,386
Next earnings
2026-10-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 225,300,000 | 107,800,000 | 3,100,000 | -11,300,000 | 3,346,000,000 | 185,500,000 | 1,253,100,000 |
| Feb 2026 | 211,200,000 | 99,000,000 | -3,300,000 | -17,000,000 | 3,359,000,000 | 159,900,000 | 1,256,600,000 |
| Nov 2025 | 224,691,000 | 106,684,000 | -5,377,000 | -15,924,000 | 3,359,953,000 | 145,340,000 | 1,255,465,000 |
| Aug 2025 | 209,189,000 | 94,970,000 | -16,091,000 | 36,338,000 | 3,378,156,000 | 138,883,000 | 1,259,507,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$83,200,000
Investing CF
$70,500,000
Financing CF
$-99,400,000
CapEx
$-51,300,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.80
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-544,300,000
Inventory
$144,300,000
Receivables
$146,800,000
ST Investments
$0
EBIT TTM
$50,134,000
Pretax Income TTM
$-8,956,000
Interest Exp TTM
$59,090,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$870,400,000
EBITDA
$94,700,000
Free Cash Flow
$69,500,000
Enterprise Value
$3,195,799,808
Total Cash
$185,500,000
Total Debt
$812,600,000
Shares Out
218,106,005
Trailing EPS
$-0.04
Book Value
$9.61
ROE
-0.4%
ROA
-0.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| May 2026 | 870,400,000 | -21,600,000 | -7,900,000 | 3,346,000,000 | 1,253,100,000 | 2,092,900,000 | 83,200,000 |
| May 2025 | 894,700,000 | -1,700,000 | -1,092,000,000 | 3,443,800,000 | 1,372,600,000 | 2,071,200,000 | 58,200,000 |
| May 2024 | 924,200,000 | 58,600,000 | -9,400,000 | 4,548,833,000 | 1,404,691,000 | 3,144,142,000 | 35,300,000 |
| May 2023 | 822,447,000 | 37,515,000 | -22,870,000 | 4,554,432,000 | 1,420,215,000 | 3,134,217,000 | 41,028,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.38
Max Pain — expiry 2026-12-18
max pain strike: $7.50 · spot: $13.72 · call oi: 0 · put oi: 1,323Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | $2.47B | $31.49 | — |
| ABSI | Absci Corp | $1.63B | $9.49 | — |
| NTLA | Intellia Therapeutics, Inc. | $1.60B | $11.42 | — |
| LNTH | Lantheus Holdings, Inc. | $6.51B | $99.74 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $797.49M | $7.75 | — |
News headlines (Yahoo Finance, 1h cache)
Neogen (NEOG) Stock Looks Fully Valued On Its Sales Base
2026-09-24 12:13 · Yahoo
3 Healthcare Stocks We’re Skeptical Of
2026-09-23 10:37 · Yahoo
Neogen Announces First-Quarter Earnings Release Date
2026-09-15 20:30 · Yahoo
Neogen (NEOG): Buy, Sell, or Hold Post Q2 Earnings?
2026-09-11 20:27 · Yahoo
Is This the Right Time to Add Neogen Stock to Your Portfolio?
2026-09-10 14:02 · Yahoo
Neogen to Host Investor Day on October 7, 2026
2026-09-08 13:00 · Yahoo
Neogen (NEOG) Following Sales Pressure And Higher Debt, Is The Rebound Already Priced In
2026-09-03 21:09 · Yahoo
PBH or NEOG: Which Is the Better Value Stock Right Now?
2026-09-14 15:40 · Yahoo
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
2026-09-28 17:31 · Yahoo
1 High-Flying Stock for Long-Term Investors and 2 We Brush Off
2026-09-28 09:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.